335 related articles for article (PubMed ID: 18508410)
41. Anti-Fc gamma receptor autoantibodies from patients with Sjögren's syndrome do not react with native receptor on human polymorphonuclear leukocytes.
Lamour A; Le Corre R; Soubrane C; Khayat D; Youinou P
J Autoimmun; 1996 Apr; 9(2):181-91. PubMed ID: 8738962
[TBL] [Abstract][Full Text] [Related]
42. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome.
Laine M; Virtanen I; Salo T; Konttinen YT
Arthritis Rheum; 2004 Dec; 50(12):3968-73. PubMed ID: 15593200
[TBL] [Abstract][Full Text] [Related]
43. Salivary resistin reflects local inflammation in Sjögren's syndrome.
Boström EA; d'Elia HF; Dahlgren U; Simark-Mattsson C; Hasséus B; Carlsten H; Tarkowski A; Bokarewa M
J Rheumatol; 2008 Oct; 35(10):2005-11. PubMed ID: 18709689
[TBL] [Abstract][Full Text] [Related]
44. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
[TBL] [Abstract][Full Text] [Related]
45. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
46. Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sjögren's syndrome.
Cavill D; Waterman SA; Gordon TP
J Rheumatol; 2002 Jun; 29(6):1342-4. PubMed ID: 12064859
[No Abstract] [Full Text] [Related]
47. Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren's syndrome.
van Woerkom JM; Kruize AA; Barendregt PJ; Kater L; Hené R; Bootsma H; Custers RJ; Jacobs JW; Bijlsma JW
Rheumatology (Oxford); 2006 Apr; 45(4):470-7. PubMed ID: 16287920
[TBL] [Abstract][Full Text] [Related]
48. [Abnormal interferon-inducible protein-10 expression in the labial glands of patients with Sjogren's syndrome].
Zhou W; Dong Y; Zhao Y; Tang FL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):603-7. PubMed ID: 14650168
[TBL] [Abstract][Full Text] [Related]
49. Abnormal basement membrane type IV collagen alpha-chain composition in labial salivary glands in Sjögren's syndrome.
Poduval P; Sillat T; Virtanen I; Porola P; Konttinen YT
Arthritis Rheum; 2009 Apr; 60(4):938-45. PubMed ID: 19333954
[TBL] [Abstract][Full Text] [Related]
50. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.
Kim N; Shin Y; Choi S; Namkoong E; Kim M; Lee J; Song Y; Park K
J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251
[TBL] [Abstract][Full Text] [Related]
51. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
52. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
[TBL] [Abstract][Full Text] [Related]
53. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
Zadura AF; Theander E; Blom AM; Trouw LA
Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
[TBL] [Abstract][Full Text] [Related]
54. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
[TBL] [Abstract][Full Text] [Related]
55. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.
Naito Y; Matsumoto I; Wakamatsu E; Goto D; Sugiyama T; Matsumura R; Ito S; Tsutsumi A; Sumida T
Ann Rheum Dis; 2005 Mar; 64(3):510-1. PubMed ID: 15708912
[No Abstract] [Full Text] [Related]
56. Expression of the interferon-gamma-inducible 10-kd protein and CXC receptor 3 in the salivary gland lesions of patients with Sjögren's syndrome: comment on the article by Ogawa et al.
Sfriso P; Calabrese F; Grava C; Agostini C; Punzi L; Oliviero F; Botsios C; Ostuni PA; Todesco S
Arthritis Rheum; 2003 Aug; 48(8):2390-1; author reply 2391-2. PubMed ID: 12905497
[No Abstract] [Full Text] [Related]
57. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors.
Bacman SR; Berra A; Sterin-Borda L; Borda ES
Curr Eye Res; 1998 Dec; 17(12):1135-42. PubMed ID: 9872535
[TBL] [Abstract][Full Text] [Related]
58. Phenotypic diversity of peripheral blood plasma cells in primary Sjögren's syndrome.
Szyszko EA; Brun JG; Skarstein K; Peck AB; Jonsson R; Brokstad KA
Scand J Immunol; 2011 Jan; 73(1):18-28. PubMed ID: 21128999
[TBL] [Abstract][Full Text] [Related]
59. Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets.
Stea EA; Routsias JG; Samiotaki M; Panayotou G; Papalambros E; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2007 Jan; 147(1):81-9. PubMed ID: 17177966
[TBL] [Abstract][Full Text] [Related]
60. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?
Dawson L; Tobin A; Smith P; Gordon T
Arthritis Rheum; 2005 Oct; 52(10):2984-95. PubMed ID: 16200578
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
